Picture of NKGen Biotech Korea logo

182400 — NKGen Biotech Korea News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: ATGen to buy stake in NK MAX for 27.47 bln won

June 22 (Reuters) - ATGen  182400.KQ  :
    * Says it plans to buy 1,526,000 shares of NK MAX Co., Ltd,
a cell
therapy products firm, for 27.47 billion won 
    * It will hold 40.74 percent stake(6,851,735 shares) in
target
company after transaction 


    Source text in Korean : https://goo.gl/vYaN8i
    Further company coverage:  182400.KQ 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))

Recent news on NKGen Biotech Korea

See all news